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Abstract
Objective—There are limited data on the natural history and longitudinal changes of retinal
microvascular lesions. We examined 10-year changes in retinal microvascular lesions, focusing on
those related to hypertension and shown to predict development of cardiovascular disease.
Design—Prospective cohort
Participants—1,120 middle-aged participants without diabetes of the Atherosclerosis Risk in
Communities (ARIC) Study in 1993–5 and again 10 years later in 2003–5.
Methods—. Retinal microvascular lesions were graded from retinal photographs using the same
protocol at both examinations, with changes (incidence or disappearance) adjudicated by a side-
by-side comparison of photographs. The study sample was stratified by carotid intima-media
thickness (IMT) and ARIC field center; thus all analyses were weighted by these factors. Persons
with diabetes were excluded because the frequency and pathophysiology of diabetic retinal lesions
is different.
Main Outcome Measures—Incidence and disappearance rates of lesions.
Results—. The 10 year incidence of focal arteriolar narrowing, arteriovenous (AV) nicking, and
retinopathy in persons without diabetes was 3.4% (95% confidence intervals 2.3–4.9), 2.5% (1.6–
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3.9), and 2.2% (1.3–3.5) respectively. Over the 10 year period, of 32, 219, and 24 eyes with focal
arteriolar narrowing, AV nicking and retinopathy at baseline, 50.3% (28.6–71.9), 40.7% (32.7–
49.4) and 65.9% (42.4–83.5), respectively, disappeared. Higher baseline plasma fibrinogen and
white cell count were associated with incident focal arteriolar narrowing; antihypertensive
medication use associated with incident AV nicking; and higher diastolic blood pressure, carotid
IMT and white cell count associated with incident retinopathy. Higher fasting serum glucose was
not significantly associated with incident retinopathy, though this may be related to the small
number of lesions.(Odds ratio 5.88, 95% confidence interval 0.74–46.64 per standard deviation
difference)
Conclusions—In this sample of middle-aged adults, new retinal microvascular lesions appeared
at a rate between 2–4% over 10 years. A high percentage of lesions (40% or more) disappeared
over the same period, suggesting considerable remodeling in the retinal microvasculature.
Keywords
microvascular signs; hypertension; microcirculation; retina; ARIC
INTRODUCTION
Retinal microvascular lesions such as focal arteriolar narrowing, arteriovenous (AV) nicking
and retinopathy lesions (e.g., microaneurysms, hemorrhages, and cotton wool spots) are
strongly associated with systemic vascular disease such as hypertension1 and may be
markers of cerebral small vessel disease.2;3 cerebral atrophy and cognitive decline 4–6. They
are also known to predict incident coronary heart disease,2;7 cardiac failure,8 stroke3, and
cardiovascular mortality.9–11 These lesions are present in 2–15% of the general population
and appear to be markers of microvascular damage from elevated blood pressure,
inflammatory processes and vascular endothelial dysfunction.12 However, despite their
importance as clinical markers of end organ damage, few prospective studies have examined
the incidence and disappearance rates of these retinal lesions, or the factors influencing these
rates. 13–15 Such data are needed to better understand the evolution of retinal microvascular
disease.
We have previously reported cross-sectional data on atherosclerotic risk factor associations
of retinal microvascular lesions.2;16;17 In the present study we describe the 10-year
incidence and disappearance of retinal microvascular lesions and their relationship to
vascular disease risk factors in participants without diabetes from the same population-based
cohort. Participants with diabetes were excluded as the pathophysiology of retinal




The Atherosclerosis Risk In Communities (ARIC) study is a population-based cohort study
that included 15,792 women and men 45–64 years of age at recruitment in 1987 through
1989. Further details are published elsewhere 19;20 The current analysis comprises a
subgroup of 1,120 persons who participated at the third examination and the Carotid MRI
(Magnetic Resonance Imaging) substudy 10 years later, as these were the 2 examinations
where retinal photography was performed. Of the 12,887 participants at the third
examination (visit 3), 2066 returned for Carotid MRI 10 years later. From these 2066
persons, we excluded 530 and 259 who did not have retinal photographs or had ungradable
photographs at visit 3 and Carotid MRI respectively, 150 who had diabetes, and 7 with
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missing data on other variables, leaving 1,120 for this analysis. Persons with diabetes were
excluded because the prevalence of retinal microvascular lesions is very much higher, and
the underlying pathophysiology is different.18
Sampling of Carotid MRI substudy
The ARIC Carotid MRI substudy re-examined 2066 surviving participants in 2005–2006
where they underwent repeat retinal photography, carotid ultrasound and brain MRI.21 The
sample was selected to achieve approximately 1200 participants with high carotid intima-
media thickness (IMT) values at their last ARIC ultrasound examination and an additional
800 participants randomly sampled from the remainder of the carotid IMT distribution.
Field-center-specific cutpoints of carotid IMT were used to achieve this, with 100%
sampling above the cutpoint, and a sampling fraction below the cutpoint to achieve the
desired 800 participant total. The cutpoints were 1.35, 1.00, 1.28, and 1.22mm IMT at
Forsyth County, Jackson, Minneapolis suburbs, and Washington County, respectively,
representing the 73rd, 69th, 73rd, and 68th percentiles of maximal IMT. Participants were
ineligible for the substudy if they had standard contraindications to MRI or contrast agent,
carotid revascularization on either side for the low IMT group or on the side selected for
imaging for the high IMT group, or difficulties in completing informed consent. A total of
4306 persons were contacted and invited to participate in the substudy; 1403 refused, 346
were ineligible, 491 reported medical conditions which precluded their participation, and
2066 (48%) participated. Those who refused were more likely to be African American, and
have diabetes, hypertension, and obesity, compared to those who participated. 21
Institutional review boards at each study site and at the University of Wisconsin, Madison
where the Ocular Epidemiology Photograph Reading Center is located, approved the study.
Informed consent was obtained from all participants and the study was conducted in
accordance with the Declaration of Helsinki.
Assessment of Retinal Microvascular Lesions
The retinal photography procedure and grading of retinal microvascular lesions have been
described in detail elsewhere.12;22 Briefly, retinal photographs using film of 1 randomly
selected eye of each participant was taken at visit 3. If the eye selected randomly was
considered too difficult or not possible to photograph with adequate quality (e.g., inability to
dilate the pupil to at least 4 mm, inability to fixate adequately for proper photographic field
definition, or opacities of the ocular media preventing a reasonably clear view of the retina),
the other eye was photographed instead. Following 5 minutes of dark adaptation, a 45-
degree photograph was taken, centered on the region of the optic disc and the macula, using
an auto-focus camera. The same eye was re-photographed at carotid MRI about 10 years
later.
Trained graders masked to participant characteristics at the Ocular Epidemiology
Photograph Reading Center, University of Wisconsin-Madison, examined the photographs
for the presence of retinal vascular abnormalities, including (1) focal arteriolar narrowing (2)
arteriovenous (AV) nicking and (3) retinopathy lesions (such as microaneurysms, retinal
hemorrhages, cotton wool spots and hard exudates). The grading and definition of these
lesions were based on a standard protocol described in other reports, and identical between
visit 3 and follow-up.22 Incidence was defined as the appearance of a retinal microvascular
sign at the carotid MRI examination in persons who did not have that sign 10 years earlier at
the visit 3 examination. Disappearance was defined as the absence at carotid MRI of a
previously documented lesion at visit 3. When a lesion appeared or disappeared, side-by-
side grading, masked by subject information, was performed by another grader to ensure the
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change was real and not due to differences in the photographic field, quality of the
photograph, or grader error.
Quality control procedures for retinal photography and grading have been previously
reported.22 The reliability of retinal microvascular sign assessment is moderate to high in the
ARIC study for most lesions, with repeated grading of photographs during earlier visits (3
and 4) showing intra-grader and inter-grader weight kappas of 0.57 and 0.56 for AV nicking,
0.62 and 0.29 for focal arteriolar narrowing, and ranging from 0.81 to 1.00 for retinopathy
lesions.12 Intra-individual reliability coefficients were generally high.23
Definition of Other Variables
Participants underwent standardized evaluations at each examination.19 At each
examination, blood pressures were taken with a random-zero sphygmomanometer, and the
mean of the last 2 of 3 measurements was used for analysis. Hypertension and diabetes
history, cigarette smoking, alcohol consumption, and use of anti-hypertensive and diabetic
medications were ascertained by questionnaire. Hypertension was defined as systolic blood
pressure (BP)≥140 mmHg, diastolic BP≥90 mmHg, or use of anti-hypertensive medication
during the previous 2 weeks. Mean arterial BP was defined as 2/3 systolic BP + 1/3 diastolic
BP. Diabetes mellitus was defined as a fasting glucose ≥126 mg/dl (≥7.0 mmol/L), a non-
fasting glucose ≥200mg/dl (≥11.1 mmol/L), or a self-reported history of physician-
diagnosed diabetes or pharmaceutical treatment for diabetes. Total plasma cholesterol and
triglycerides were measured by enzymatic methods, High Density Lipoprotein (HDL)
cholesterol was measured after dextran-magnesium precipitation of the non-HDL
lipoproteins, and glucose was measured by the modified hexokinase/glucose-6-phosphate
dehydrogenase procedure. Platelet and white blood cell counts were measured by Coulter
counter. Venous blood was drawn after an 8-hour fast for measuring fibrinogen, factor VIII,
and von Willebrand factor (vWF) antigen at visit 1. Fibrinogen was measured by thrombin-
time titration; factor VIII activity, by clotting time with the use of factor VIII–deficient
plasma; and vWF antigen, by ELISA kits. Height and weight were measured for calculation
of body mass index (BMI). Mean carotid intima media thickness (IMT) was derived from
standardized B-mode ultrasonograms at visit 3 or imputed from readings taken at visit 4.24
Other variables were based on the visit 3 examination at the time of retinal photography.
Statistical methods
All analyses were based on methods appropriate for stratified random sampling. Analyses
were weighted by the inverse of the sampling fractions in the 8 sampling strata (2 IMT strata
X 4 field centers) - e.g., the sampling weight for a given individual was the reciprocal of (the
number participating from a given IMT stratum at a given field center/the number from the
same stratum at the same field center who were invited to participate). Continuous risk
factors such as blood pressure were standardized using 1 standard deviation of exposure. We
constructed logistic models adjusted for age (continuous), race, and gender, to examine the
association between single risk factors and arteriovenous nicking, focal arteriolar narrowing,
and diabetic retinopathy. SAS software (version 9.1, SAS Institute) was used for analysis of
descriptive statistics and SUDAAN (RTI International) was used for logistic regression.
(Details of variance and parameter estimation are given in Sections 4.8 and 10.9 of Research
Triangle Institute (2004). SUDAAN Language Manual, Release 9.0. Research Triangle Park,
NC.).
RESULTS
Table 1 shows the characteristics of included and excluded participants without diabetes,
based on their baseline values at visit 3. Participants who were included were slightly
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younger, less likely to be African-American, and less likely to have hypertension and other
cardiovascular risk factors. Over the 10-year period between visit 3 and carotid MRI, the
weighted incidence of focal arteriolar narrowing, AV nicking and retinopathy lesions in
persons without diabetes was 3.4% (95% confidence interval 2,3–4.9), 2.5% (1.6–3.9) and
2.2% (1.3–3.5) respectively (Table 2). A substantial percentage of retinal microvascular
lesions observed at visit 3 had disappeared by carotid MRI, ranging from 40.7% (32.7–49.4)
for AV nicking, to 50.3% (28.6–71.9) for focal arteriolar narrowing, to 65.9% (42.4–83.5)
for retinopathy in persons without diabetes. Incidence and disappearance rates were similar
in white and African American participants.
Table 3 examines odds ratios associated with per SD differences of individual risk factors,
considered separately and adjusted for age, gender and race. Higher plasma fibrinogen and
white blood cell count were associated with higher incidence of focal arteriolar narrowing;
antihypertensive medication use was associated with higher incidence of arteriovenous
nicking; and higher diastolic BP, higher carotid IMT and higher white cell count were
associated with higher incidence of retinopathy (Table 3). Systolic BP (Odds Ratio 1.46,
95% confidence interval 0,90–2.39) mean arterial BP (1.54, 0.97–2.42) and fasting glucose
(5.88, 0.74–46.64) were not associated with incidence of any of these lesions,. None of the
factors in Table 3 was associated with disappearance of retinal microvascular lesions over
10 years, as compared to participants with these signs persisting from visit 3 to follow-up.
(data not shown)
DISCUSSION
The retinal microcirculation can be directly visualized and provides an opportunity to assess
longitudinal changes in microvascular structure. In this cohort of middle-aged individuals
free from diabetes, we report that the 10-year incidence of new retinal microvascular lesions
is between 2–4%. In persons with existing lesions at baseline, close to half or more of these
lesions (40–66%) disappeared over the same period of time.
In the ARIC study, we previously reported 2.9% incidence of retinopathy in persons without
diabetes over 3 years in a subsample of 981 participants who had retinal photography at visit
3 and visit 4.25 We now report that the 10-year incident retinopathy rate in a different ARIC
subsample of 1120 individuals appears to be slightly lower at 2.2% (1.3–3.5), though still
within the 95% confidence interval estimates. The lower 10-year incidence estimate may be
due to lower prevalence of hypertension (29% vs 44%), and more stringent side by side
grading performed for this analysis. Additionally, the lower 10-year incidence rates may
also reflect the high rate of regression, with almost 2 in 3 nondiabetic participants with
retinopathy at baseline found to have no lesions after 10 years. Thus, it is possible that 2–3%
represents a steady state of “incidence” and “disappearance” of these lesions. This
possibility is supported by the difference in 10-year prevalence of retinopathy in the baseline
ARIC, Beaver Dam and Blue Mountains Eye studies, which show a 2–3% higher prevalence
of retinopathy per higher decade.12;14;26
The incidence rates of retinal microvascular lesions in ARIC are lower than reported from
other studies, although studies are not directly comparable. Table 4 is intended to provide an
overview of the estimates from different studies, but it should be noted that methodological
differences may underlie the different rates reported. In the Beaver Dam Eye Study (US), 13
about 6–10% of participants without diabetes developed incident retinal microvascular
lesions over a 5-year period. In the Blue Mountains Eye Study (Australia)14, 10% of an
older population without diabetes developed incident retinopathy after 5 years, while in the
Hoorn Study (Netherlands) 15, 7.3% of persons without diabetes developed incident
retinopathy over 9.4years. In the ARIC study, we used a 45° non-mydriatic retinal
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photograph of only 1 eye to define presence or absence of retinopathy lesions, while the
Beaver Dam Eye Study used 30° stereoscopic mydriatic photographs of 2 eyes,13 the Blue
Mountains Eye Study defined retinopathy from six-field 30° stereoscopic retinal
photographs of 2 eyes,14 and the Hoorn study used 45° mydriatic retinal photographs of 2
eyes.15 Additionally, both the Blue Mountains and Beaver Dam Eye studies validated
incident cases by a side-by-side assessment of the retinal photographs performed at baseline
and follow up of patients who developed incident retinopathy. Differences in study
participant characteristics (e.g., age and prevalence of risk factors between studies) may also
contribute to the variation in incidence rates of retinopathy. Nonetheless our data is valuable
as we report both incidence and disappearance of lesions, and relate them to carefully
measured cardiovascular risk factors from a study designed to measure these risk factors.
We considered the possibility that the high rate of apparent regression of retinal
microvascular lesions may be due to misclassification at the carotid MRI grading and thus
re-examined simultaneously side by side photos with lesions at both visit 3 and follow-up.
This showed minimal misclassification (net 1 out of 219 AV nicking lesions at baseline was
reclassified) that was unlikely to meaningfully influence our results. The same high rate of
regression of retinopathy was also reported in the Blue Mountains Study,14 earlier ARIC
data showing 64% of retinopathy in persons without diabetes regressed over 3 years 25 as
well as a clinic study which documented over 50% regression of microaneurysms (graded
from fundus fluorescein angiograms) over 2 years in persons with diabetes.27 These results
highlight the transient nature of retinopathy lesions and is consistent with their known
biology, as microaneurysms can become nonperfused and hemorrhages and exudates are
resorbed over a period of months. A study in persons with malignant hypertension found
almost complete resolution of retinopathy lesions within 6–12 months once elevated BP is
controlled, although focal arteriolar narrowing and AV nicking persisted.28 In our study, the
high disappearance rate of focal arteriolar narrowing and AV nicking may be related to the
long follow up, and less severe lesions as the majority of participants had only mild or no
hypertension. It should be noted that we defined retinopathy to be consistent and comparable
with earlier studies. In preliminary analyses the incidence of more severe forms of
retinopathy involving at least 1 microaneurysm was lower, around 1.5%.
Antihypertensive medication use, which may indicate more severe hypertension, was
associated with increased incidence of AV nicking but not with other lesions. Higher
diastolic BP, carotid IMT and white cell count was associated with incident retinopathy. The
association of higher carotid IMT with incident retinopathy is consistent with clinic studies
showing increased prevalence of retinopathy lesions in persons with severe carotid occlusive
disease.29 Carotid IMT is a measure of subclinical atherosclerosis, with higher values
indicating more advanced disease. Retinopathy lesions in such individuals may be due to
embolization to the retinal microvasculature or the ocular ischemic syndrome, which is
usually associated with >75% stenosis of the carotid artery.29 White cell count is a marker
for systemic inflammation, and the Hoorn study has reported that other inflammatory
markers such as C-reactive protein are associated with prevalent retinopathy in persons
without diabetes.30 The Hoorn study also reported an association of endothelial
dysfunction30 with retinopathy and it is noteworthy that our results indicate a weak
association of von Willebrand factor with incident retinopathy. The pathogenesis of
retinopathy in persons without diabetes is poorly understood and our findings suggest a role
for elevated diastolic BP, carotid disease and inflammation. Although fasting glucose was
not significantly associated with incident retinopathy, the OR of 5.88 (0.74, 46.64) per SD
change in fasting glucose is highly suggestive, while lack of statistical significance is likely
related to the small number of incident lesions and the limited number of individuals with
high fasting glucose in this nondiabetic sample. This is consistent with the known moderate
association of retinopathy and incident diabetes.13 Higher white cell count and fibrinogen
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were associated with incident focal arteriolar narrowing. The first 2 parameters are
inflammatory markers and may be associated with impaired endothelium dependent
vasodilation,31 leading to vasoconstriction seen clinically as focal arteriolar narrowing.
Little data is available on the disappearance of focal arteriolar narrowing and AV nicking.
Focal arteriolar narrowing secondary to localized vasoconstriction may attenuate over years
leading to loss of this lesion, or it could have progressed from focal narrowing to overall
generalized narrowing so that “disappearance” was not necessarily indicative of
“regression”. AV nicking is traditionally related to compression of venules within a common
adventitial sheath due to arteriolar sclerosis and medial thickening at AV crossings.32
Resolution of this lesion is thus somewhat surprising and suggests a high degree of
remodeling of vessel walls or the adventitial sheath over a period of years. Our study did not
identify any factors associated with lesion disappearance, a likely consequence of the limited
number of lesions at baseline, although AV nicking was one of the more frequent lesions at
baseline. To our knowledge, this is the first study to report regression rates of focal
narrowing and AV nicking.
Our study has several strengths including a prospective design with 10-year follow up and
standardized measurement of a range of retinal microvascular lesions including side by side
grading. Several limitations should be considered. First, although the initial sample was
population based, the sampling 10 years later was stratified according to carotid IMT and
ARIC field center. We applied sampling weights and robust variance estimation in all
analyses to adjust for the effects of stratification. Nonetheless, such statistical adjustment
may be less robust than true random sampling of the follow-up population, and should be
considered when interpreting our findings. Secondly, we only graded and examined the
changes in retinal microvascular lesions from 1 eye. This would underestimate the incidence
of new lesions and may partly account for the lower rates reported from our study. Thirdly,
the number of some lesions at baseline, particularly focal arteriolar narrowing and
retinopathy, is low and the estimates of incidence and disappearance are thus imprecise with
wide confidence intervals. For the same reason, the associations observed here could have
occurred by chance. Fourthly, retinal microvascular signs are associated with increased
mortality,2;10;11 and a form of survival bias may have influenced our results whereby
persons with more severe retinal lesions were more likely to die and thus not be included in
the follow-up. Without knowing the natural history of retinal lesions in persons with high
mortality, it is not possible to be certain how this effect may bias our results, but we
speculate that more severe lesions may be less likely to regress, and thus this may help
explain part of the high rate of lesion disappearance.
With these limitations in mind, our findings have clinical implications as prevalent retinal
microvascular lesions are known to be independent markers of increased risk of developing
hypertension and cardiovascular disease risk.2;17 It remains unclear whether the
disappearance of these lesions modifies the risk of developing hypertension or other
cardiovascular diseases. Continuing surveillance of this ARIC cohort may help determine if
disappearance of lesions is associated with decreased cardiovascular risk. The high rate of
lesion disappearance also suggests that a high degree of microvascular remodeling occurs
over time. Future research to identify factors associated with this phenomenon is warranted.
In summary, we report in this selected sample of middle-aged adults the 10-year incidence
of new retinal microvascular lesions (focal arteriolar narrowing, AV nicking and
retinopathy) is between 2–4%. A high percentage of lesions (40–66%), disappeared over the
same time period, suggesting a considerable degree of microvascular remodeling. Some
cardiovascular risk factors including use of antihypertensive medication, higher diastolic
BP, markers of inflammation and higher carotid IMT were associated with incidence of new
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lesions. Our findings help clarify the natural history of retinal microvascular lesions in
persons without diabetes.
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